Skip to main navigation Skip to search Skip to main content

SBIR: Novel Recombinant BCG for Immunotherapy of Bladder Cancer

Project: Research

Project Details

StatusFinished
Effective start/end date09/1/1808/31/20

Funding

  • National Institutes of Health: $85,266.75